Inventor · disambiguated record
Jae Sik Shin
Also filed as: SHIN JAE SIK
6 granted patents·7 pending applications·1 citations·filing 2014–2022
67Inventor score
Top patents by PatentIndex Score
13 records- 0169US11447500B2Thienopyridine derivatives and pharmaceutical composition comprising sameWELLMARKER BIO CO LTD·Filed 2019·Granted Sep 20, 2022·1 cites·15 claims
- 0262US2021292848A1Novel biomarker for predicting sensitiviy to egfr-targeting agent, and use thereofWELLMARKER BIO CO LTD·Filed 2021·Application pending·0 cites
- 0362US2021292849A1Novel biomarker for predicting sensitivity to egfr-targeting agent, and use thereofWELLMARKER BIO CO LTD·Filed 2021·Application pending·0 cites
- 0458US11008622B2Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereofASAN FOUND·Filed 2015·Granted May 18, 2021·0 cites·3 claims
- 0556US2020354794A1Method for determining sensitivity to simultaneous inhibitor against parp and tankyraseASAN FOUND·Filed 2020·Application pending·0 cites
- 0654US10683553B2Method for determining sensitivity to simultaneous inhibitor against PARP and TankyraseASAN FOUND·Filed 2016·Granted Jun 16, 2020·0 cites·4 claims
- 0753US2022288043A1Thienopyridine derivatives and pharmaceutical composition comprising sameWELLMARKER BIO CO LTD·Filed 2022·Application pending·0 cites
- 0850US2023346790A1Pharmaceutical composition for prevention or treatment of cancers associated with kras mutationWELLMARKER BIO CO LTD·Filed 2021·Application pending·0 cites
- 0949US2023099204A1Pharmaceutical composition for prevention or treatment of cancer in which kras mutation and activated ron are presentWELLMARKER BIO CO LTD·Filed 2021·Application pending·0 cites
- 1048US2023172914A1Biomarker-based therapeutic compositionWELLMARKER BIO CO LTD·Filed 2019·Application pending·0 cites
- 1145US11186873B2Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)WELLMARKER BIO CO LTD·Filed 2015·Granted Nov 30, 2021·0 cites·15 claims
- 1245US9752151B2Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredientASAN FOUND·Filed 2014·Granted Sep 5, 2017·0 cites·2 claims
- 1334US11946934B2Biomarker for predicting the sensitivity to a protein kinase inhibitor and a use thereofWELLMARKER BIO CO LTD·Filed 2015·Granted Apr 2, 2024·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Jae Sik Shin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →